AI assistant
SURMODICS INC — Director's Dealing 2019
Apr 3, 2019
32845_dirs_2019-04-03_8452c622-f464-4ab9-9b91-d2c2a8d401a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2019-04-01
Reporting Person: Maharaj Gary R (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-04-01 | Common Stock | S | 5000 | $42.8996 | Disposed | 162205 | Direct |
Footnotes
F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019.
F2: Reflects the weighted average price of 5,000 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on April 1, 2019 with sale prices ranging from $42.62 to $43.34 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Includes 171 shares acquired through the Employee Stock Purchase Plan for the phase ending 2/28/19.